Puromed Global Private Limited

Dapasmart 5mg Tablet is a prescription medication used to manage type 2 diabetes. Its active ingredient is Dapagliflozin. It is manufactured by Healing Pharma India Private Limited. 

Dapagliflozin+Glimepiride+Metformin is used in the treatment of type 2 diabetes mellitus. Dapagliflozin + Glimepiride + Metformin is a combination of three antidiabetic medications. Dapagliflozin lowers blood sugar by causing the kidneys to get rid of more glucose in the urine.

Dapasmart GM 2/1000 is a medication used to treat type 2 diabetes. It combines three active ingredients: dapagliflozin, glimepiride, and metformin. Dapagliflozin helps remove excess glucose through urine, while glimepiride stimulates insulin release from the pancreas, and metformin reduces glucose production in the liver and improves insulin sensitivity. 

It is used for the treatment of type 2 diabetes along with diet and exercise. Dapasmart lowers high blood sugar levels by excreting excess blood sugar through urine. Take this medicine as prescribed and for the duration that it is prescribed by your doctor.

Dapasmart M includes two key components: Dapagliflozin and Metformin. Dapagliflozin falls under the category of SGLT2 inhibitors, whereas Metformin is classified as a biguanide. This combined medication is prescribed for type 2 diabetes management, aiding in the reduction of blood sugar levels. Dapagliflozin enhances sugar elimination via the kidneys, while Metformin diminishes sugar production in the liver and enhances insulin sensitivity.

The Dapasmart Trio 500 tablet is primarily used to manage type 2 diabetes mellitus in adults. It is a combination medicine that helps control blood sugar levels when diet, exercise, and single or dual therapies are insufficient. 

Dapasmart Trio Forte 1000 Tablet 10 is used to manage type 2 diabetes mellitus in adults whose blood sugar levels are not adequately controlled by metformin alone. It combines dapagliflozin, sitagliptin, and metformin to help control blood sugar levels.

Linasmart Dapa  is a combination medication used to manage type 2 diabetes. It contains linagliptin and dapagliflozin, both of which work to lower blood sugar levels. Linagliptin is a DPP-4 inhibitor that helps increase insulin secretion and reduce glucose production. Dapagliflozin is an SGLT2 inhibitor that blocks the reabsorption of glucose in the kidneys, increasing its excretion in the urine.